These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 10379019

  • 1. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.
    N Engl J Med; 1999 Jun 24; 340(25):1954-61. PubMed ID: 10379019
    [Abstract] [Full Text] [Related]

  • 2. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD, U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Med Pediatr Oncol; 2001 Jan 24; 36(1):14-9. PubMed ID: 11464868
    [Abstract] [Full Text] [Related]

  • 3. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.
    N Engl J Med; 1996 Jan 25; 334(4):225-30. PubMed ID: 8531999
    [Abstract] [Full Text] [Related]

  • 4. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B.
    Med Pediatr Oncol; 2001 Jan 25; 36(1):11-3. PubMed ID: 11464859
    [Abstract] [Full Text] [Related]

  • 5. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R, Hero B, Ernestus K, Berthold F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4835-40. PubMed ID: 14581355
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T, Sjöberg RM, Hedborg F, Kogner P.
    Cancer Res; 1995 Dec 01; 55(23):5681-6. PubMed ID: 7585654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM.
    N Engl J Med; 1993 Mar 25; 328(12):847-54. PubMed ID: 8441429
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status.
    Cunsolo CL, Bicocchi MP, Petti AR, Tonini GP.
    Br J Cancer; 2000 Nov 25; 83(10):1295-300. PubMed ID: 11044353
    [Abstract] [Full Text] [Related]

  • 13. [The neuroblastoma, "enfant terrible" among pediatric tumors].
    Laureys G.
    Verh K Acad Geneeskd Belg; 2003 Nov 25; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
    [Abstract] [Full Text] [Related]

  • 14. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
    Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM.
    Cancer Res; 1995 Oct 15; 55(20):4664-9. PubMed ID: 7553646
    [Abstract] [Full Text] [Related]

  • 15. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
    Lastowska M, Roberts P, Pearson AD, Lewis I, Wolstenholme J, Bown N.
    Genes Chromosomes Cancer; 1997 Jul 15; 19(3):143-9. PubMed ID: 9218994
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M, Berthold F, Edler L, Schwab M, Amler LC.
    Cancer Res; 1995 Nov 15; 55(22):5366-9. PubMed ID: 7585602
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.